Sector: Pharmaceuticals & Drugs
Mkt Cap: 19,127 cr
Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products.
TTM PE : -- (Average PE)
Sector PE : 49.36
Beta : 52 Week Low
Stock with consistent financial performance, quality management, and strong technical momentum indicating...
Sanofi India is near completion of its Harmonic pattern and will turn bullish.
Sanofi India is nearing its bottom and seems will bottom out close to 4796 by end of May.
Accumulation can be started from 5000
Stop Loss is 4700 on monthly closing basis
Target 1 - 7424
Target 2 - 8989
Target 3 - 9285
Sanofi has recently taken support from a monthly demand zone and broken a weekly demand zone on the daily timeframe with huge volume.
The stock was in a downtrend from August 2021 until October 2022, which was phase 4 markdown.
Since October 2022, it has been trading sideways, which can be considered accumulation phase 1.
Today, the sideways breakout has...
Sanofi on Monthly chart is on verge on forming a death cross (20-50 EMA negative crossover)
Cautious on this stock to take entry until there is some confirmation on change in trend.
In case the death cross occurs in a month or two then the below support levels are marked.
Please note: The formation is not yet completed and if there is reversal well and good,...
Sanofi India Limited is engaged in the manufacture and sale of pharmaceutical products.
Current price is more than the intrinsic value
Stock offers good dividend returns
Low probability of default in next 12 months
PE Ratio 17.87
With a market cap of ₹16,872 cr,
Over the last 5 years, revenue has grown at a yearly rate of 7.67%, vs industry avg of 6.95%
Sanofi was correcting from 11/08 from 9275 and it went down to the level of 7435 on 20/12. Since then, it is consolidating in a healthy way. It now seems to be a reversal candidate and uptrend may start soon and strongly.
1. Double Bottom
- It created double bottom with second bottom above the initial
- It created double bottom with positive RSI...
Chart is self explanatory. Entry, Targets and Stop Loss are mentioned on the chart.
Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please consult your financial advisor before taking any trade.
This is follow-up on Sanofi India. Can check link to related ideas.
Target 1 achieved. More than 6%. Target 2 is ON.
Chart is self explanatory. Entry, Targets and Trailing Stop Loss are mentioned on the chart.
Disclaimer: This is for demonstration and educational purpose only. This is not buying or selling recommendations. I am not SEBI registered. Please...
SANOFI India is engaged in business of Manufacturing & Sale of Pharmaceutical Products. Since August 2020 it is making a wedge chart pattern on daily time frame & consolidating since May 2021 for a bull run. expecting a good upside move for long term. You can take Target & SL as per trend analysis which we suggest/teach during our Beginner Module Course. Happy...